← Back to Screener
Elanco Animal Health Incorporated Common Stock (ELAN)
Price$23.13
Favorite Metrics
Price vs S&P 500 (26W)10.22%
Price vs S&P 500 (4W)-12.27%
Market Capitalization$11.55B
P/E Ratio (Annual)38.83x
All Metrics
P/CF (Annual)20.62x
Book Value / Share (Quarterly)$13.17
P/TBV (Annual)3.58x
Revenue Growth (3Y)2.25%
Cash Flow / Share (Quarterly)$0.57
Price vs S&P 500 (YTD)0.01%
Gross Margin (TTM)54.99%
Net Profit Margin (TTM)-4.92%
EPS (TTM)$-0.48
10-Day Avg Trading Volume4.30M
EPS Excl Extra (TTM)$-0.48
Revenue Growth (5Y)7.59%
EPS (Annual)$-0.47
ROI (Annual)-2.20%
Gross Margin (Annual)54.99%
Net Profit Margin (5Y Avg)-7.42%
Cash / Share (Quarterly)$1.10
P/E Basic Excl Extra (TTM)364.59x
Revenue Growth QoQ (YoY)12.16%
EPS Growth (5Y)29.95%
P/E Normalized (Annual)38.83x
ROA (Last FY)-1.74%
Revenue Growth TTM (YoY)6.22%
EBITD / Share (TTM)$1.09
ROE (5Y Avg)-5.05%
Operating Margin (TTM)-4.35%
Cash Flow / Share (Annual)$0.57
P/B Ratio1.76x
P/B Ratio (Quarterly)1.72x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)3.19x
Net Interest Coverage (TTM)3.08x
ROA (TTM)-1.73%
EV / EBITDA (TTM)27.87x
EPS Incl Extra (Annual)$-0.47
Current Ratio (Annual)2.17x
Quick Ratio (Quarterly)0.93x
3-Month Avg Trading Volume5.18M
52-Week Price Return167.63%
EV / Free Cash Flow (Annual)52.89x
P/E Incl Extra (TTM)364.59x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$6.32
P/S Ratio (Annual)2.45x
Asset Turnover (Annual)0.35x
52-Week High$27.72
Operating Margin (5Y Avg)-1.82%
EPS Excl Extra (Annual)$-0.47
CapEx CAGR (5Y)-2.35%
Tangible BV CAGR (5Y)8.49%
26-Week Price Return14.21%
Quick Ratio (Annual)0.93x
13-Week Price Return-2.68%
Total Debt / Equity (Annual)0.61x
Current Ratio (Quarterly)2.17x
Enterprise Value$15,021.214
Revenue / Share Growth (5Y)5.09%
Asset Turnover (TTM)0.35x
Book Value / Share Growth (5Y)-6.01%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.28x
Pretax Margin (Annual)-4.75%
Cash / Share (Annual)$1.10
3-Month Return Std Dev39.76%
Gross Margin (5Y Avg)55.61%
Net Income / Employee (TTM)$-0
EBITDA CAGR (5Y)28.45%
ROE (Last FY)-3.54%
Net Interest Coverage (Annual)3.08x
EPS Basic Excl Extra (Annual)$-0.47
P/FCF (TTM)32.72x
Receivables Turnover (TTM)5.62x
EV / Free Cash Flow (TTM)52.89x
Total Debt / Equity (Quarterly)0.61x
EPS Incl Extra (TTM)$-0.48
Receivables Turnover (Annual)5.62x
ROI (TTM)-2.15%
P/S Ratio (TTM)2.45x
Pretax Margin (5Y Avg)-6.89%
Revenue / Share (Annual)$9.50
Tangible BV / Share (Annual)$6.32
Forward P/E22.45x
Free OCF CAGR (5Y)70.08%
Price vs S&P 500 (52W)137.80%
P/E Ratio (TTM)364.59x
EPS Growth TTM (YoY)-82.48%
Year-to-Date Return2.65%
5-Day Price Return-0.98%
EPS Normalized (Annual)$-0.47
ROA (5Y Avg)-2.21%
Net Profit Margin (Annual)-4.92%
Month-to-Date Return-2.93%
Cash Flow / Share (TTM)$-0.92
EBITD / Share (Annual)$1.09
Operating Margin (Annual)-4.35%
LT Debt / Equity (Annual)0.57x
P/CF (TTM)20.62x
ROI (5Y Avg)-2.66%
P/E Excl Extra (TTM)364.59x
LT Debt / Equity (Quarterly)0.60x
EPS Basic Excl Extra (TTM)$-0.48
P/TBV (Quarterly)3.58x
P/B Ratio (Annual)1.72x
Inventory Turnover (TTM)1.28x
Pretax Margin (TTM)-4.75%
Book Value / Share (Annual)$13.17
Price vs S&P 500 (13W)-3.37%
Net Margin Growth (5Y)28.06%
Beta1.82x
P/FCF (Annual)40.67x
Revenue / Share (TTM)$9.78
ROE (TTM)-3.51%
52-Week Low$8.02
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.23
4.27
4.27
4.27
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ELANElanco Animal Health Incorporated Common Stock | 2.45x | 6.22% | 54.99% | 29.95% | $23.13 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
About
Elanco Animal Health is a global pharmaceutical company serving the companion and food animal markets with products sold in over 90 countries. The company's portfolio spans cattle, sheep, goats, swine, and companion animals, built through a combination of internal development and strategic acquisitions that have strengthened its market position.